Treatment of Non Severe Hemophagocytosis Lymphohistiocytosis With ITACITINIB

Clinical trial NCT05063110 · COMPLETED

Trial details

NCT number: NCT05063110
Sponsor: Assistance Publique - Hôpitaux de Paris
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Adults Patients Having Non Severe HLH

Start date: 2022-05-03
Primary completion: 2025-04-03
Enrollment: 35

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.